C-Suite executive with more than 35 years’ experience in international banking Brings important and complementary skills to support company’s development Marseille, France, April 24, 2025 - Vect-Horus ...

Brings extensive experience in investor relations and financial research and analysis Will drive financial strategy to support internal pipeline and partnerships Marseille, France, March 25, 2025 - ...

MARSEILLE, France, Oct. 30, 2014 (GLOBE NEWSWIRE) -- VECT-HORUS, a biotechnology company that designs and develops peptide vectors facilitating the delivery of drugs or imaging agents, notably in the ...

MARSEILLE, France, and SEOUL, South Korea, Feb. 3, 2026 -- Vect-Horus, a France-based biotechnology company, and OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, ...

MARSEILLE, France--(BUSINESS WIRE)--Vect-Horus, a privately held biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging ...

MARSEILLE, France--(BUSINESS WIRE)--VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, today ...

Accomplished research scientist and business professional Brings important skills for both clinical and business development of Vect-Horus Marseille, France, November 14, 2024 - Vect-Horus, a ...

Vect-Horus and RadioMedix are pleased to announce the FDA clearance of exploratory Investigational New Drug (eIND) application to evaluate 68 Ga-RMX-VH for the detection and mapping of Low Density ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

Partnership launched under MTEA to evaluate the potential of Vect-Horus technology to deliver siRNAs into the CNSAssessment of BBB shuttle-siRNA compatibility, CNS delivery efficiency, and ...